IRVINE, CA, and HERSTAL, BELGIUM, May 29, 2015 -MDxHealth SA (Euronext: MDXH), held its Annual General Meeting of shareholders in Zaventem today. The shareholders approved all agenda items of the Annual General Meeting, including the financial statements for the financial year ended December 31, 2014.
About MDxHealth
MDxHealth is a multinational healthcare company that provides actionable epigenetic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation (epigenetic) technology and assist physicians with the diagnosis of cancer, prognosis of recurrence risk, and prediction of response to a specific therapy. For more information visit mdxhealth.com and follow us on Twitter at: twitter.com/mdxhealth.
For more information:
Dr Jan Groen, CEO
MDxHealth
US : +1 949 812 6979
BE: +32 4 364 20 70
info@mdxhealth.com
Mike Sinclair (media)
Halsin Partners
UK: +44 20 7318 2955
Cell: +44 7968 022075
msinclair@halsin.com
Help employers find you! Check out all the jobs and post your resume.
About MDxHealth
MDxHealth is a multinational healthcare company that provides actionable epigenetic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation (epigenetic) technology and assist physicians with the diagnosis of cancer, prognosis of recurrence risk, and prediction of response to a specific therapy. For more information visit mdxhealth.com and follow us on Twitter at: twitter.com/mdxhealth.
For more information:
Dr Jan Groen, CEO
MDxHealth
US : +1 949 812 6979
BE: +32 4 364 20 70
info@mdxhealth.com
Mike Sinclair (media)
Halsin Partners
UK: +44 20 7318 2955
Cell: +44 7968 022075
msinclair@halsin.com
Help employers find you! Check out all the jobs and post your resume.
